VANRAFIA .75 mg/1
atrasentan · TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
VANRAFIA is a tablet, film coated containing atrasentan at .75 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- VANRAFIA
- Generic Name
- atrasentan
- NDC Code (Product)
0078-1420- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- .75 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA219208
- Marketing Start
- 04/02/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is VANRAFIA used for?
VANRAFIA contains atrasentan. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is VANRAFIA a controlled substance?
VANRAFIA is not classified as a controlled substance by the DEA.
What is the generic name for VANRAFIA?
The generic name for VANRAFIA is atrasentan. There are no other listed brand versions of atrasentan.
What is the NDC code for VANRAFIA .75 mg/1?
The NDC (National Drug Code) for VANRAFIA .75 mg/1 is 0078-1420, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)